|
![]() |
|||
|
||||
OverviewFull Product DetailsAuthor: Iftekhar KhanPublisher: Taylor & Francis Inc Imprint: CRC Press Inc Volume: 87 Dimensions: Width: 15.60cm , Height: 2.30cm , Length: 23.40cm Weight: 0.860kg ISBN: 9781466505476ISBN 10: 1466505478 Pages: 313 Publication Date: 18 November 2015 Audience: College/higher education , General/trade , Tertiary & Higher Education , General Format: Hardback Publisher's Status: Active Availability: In Print ![]() This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of ContentsIntroduction to Economic Evaluation. Health Economic Evaluation Concepts. Designing Cost-Effectiveness into a Clinical Trial. Analyzing Cost Data Collected in a Clinical Trial. Quality of Life in Economic Evaluation. Modelling in Economic Evaluation. Sensitivity Analyses. Sample Size and Value of Information for Cost-Effectiveness Trials. Mixed Treatment Comparisons, Evidence Synthesis. Cost-Effectiveness Analyses of Cancer Trials. The Reimbursement Environment. References. Bibliography. Index.Reviews. . . the book can be highly recommended to all researchers interested in implementing health-economic evaluations in investigator-initiated studies or pharmaceutical drug trials as well as MSc and postgraduate students of economics pursuing a career in the clinical drug development. ~International Society for Clinical Biostatistics . . . the book can be highly recommended to all researchers interested in implementing health-economic evaluations in investigator-initiated studies or pharmaceutical drug trials as well as MSc and postgraduate students of economics pursuing a career in the clinical drug development. ~International Society for Clinical Biostatistics . . . the book can be highly recommended to all researchers interested in implementing health-economic evaluations in investigator-initiated studies or pharmaceutical drug trials as well as MSc and postgraduate students of economics pursuing a career in the clinical drug development. International Society for Clinical Biostatistics Author InformationIftekhar Khan is a statistician, health economics researcher and academic at University College London (University of London). He has been an applied statistician for over 15 years in clinical trials, having worked in pharmaceutical companies and academic clinical trials units. Iftekhar Khan has completed degrees in statistics and mathematics from King’s College London, the University of Kent and the University of Cambridge, including a master’s in health economics and a PhD in health economic modelling (University College London). Tab Content 6Author Website:Countries AvailableAll regions |